Healthcare -
Biotechnology - NASDAQ - GB
$ 1.38
0.362 %
$ 56.7 M
Market Cap
-0.83
P/E
ACHL - COST OF REVENUE
Cost of Revenue ACHL - Achilles Therapeutics plc
4.73 M
LAST VALUE
19.96%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR